Ropes & Gray has advised Anaqua. Anaqua, a provider of intellectual property (IP) management technology and services, has acquired Unified Patents, an international membership organization specializing...
Anaqua Acquires Unified Patents to Enhance IP Litigation Risk Management
Johnson & Johnson Completes $1 Billion Acquisition of Firefly Bio
Wilson Sonsini Goodrich & Rosati has advised Firefly Bio. Ropes & Gray has advised Johnson & Johnson. Johnson & Johnson (NYSE: JNJ) has announced the successful...
Insilico Medicine and SK Biopharmaceuticals in AI-Powered Neuroimmune Drug Discovery Collaboration
Ropes & Gray has advised SK Biopharmaceuticals. Insilico Medicine (“Insilico”, 3696.HK) and SK Biopharmaceuticals have announced a major research and development collaboration focused on discovering AI-enabled...
Akebia Therapeutics Acquires Complement Inhibitor to Build Rare Kidney Disease Pipeline
Ropes & Gray has advised Akebia Therapeutics on the deal. Akebia Therapeutics has announced the acquisition of Q32 Bio’s Phase 2 complement inhibitor drug ADX-097, a...
Monte Rosa Therapeutics and Novartis Sign $5.7 Billion Collaboration for Molecular Glue Degraders
Ropes & Gray has advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics and Novartis have entered into a collaboration agreement to develop novel molecular...
US WorldMeds Acquires Adaptimmune’s Cell Therapy Portfolio for $55 Million
Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc. US WorldMeds has entered...
Matchpoint Therapeutics Enters Into $1 Billion Option and License Agreement with Novartis
Ropes & Gray has advised Matchpoint Therapeutics on the transaction. Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis for the development...
Creyon Bio’s Licensing Collaboration with Eli Lilly
Ropes & Gray represented Creyon Bio in the transaction. Creyon Bio announced a global licensing and multi-target research collaboration with Eli Lilly and Company focused on...
1440 Foods’ Acquisition of FITCRUNCH and Bakery Barn
Ropes & Gray represented 1440 Foods in the transaction, and Finn Dixon & Herling represented FITCRUNCH and Bakery Barn. 1440 Foods, a portfolio of sports and...
Monte Rosa Therapeutics’ Global Licensing Collaboration with Novartis
Ropes & Gray advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics (Nasdaq: GLUE) has entered into a global exclusive licensing agreement with Novartis to...
Adaptimmune’s Clinical Collaboration Agreement with Galapagos
Ropes & Gray advised Adaptimmune Therapeutics on the transaction. Adaptimmune Therapeutics (NASDAQ: ADAP) announced it has entered into a clinical collaboration agreement with Galapagos NV (Euronext...
Adaptimmune’s $125 Million Debt Financing with Hercules Capital
Ropes & Gray advised Adaptimmune Therapeutics plc on the transaction, and DLA Piper advised Hercules Capital. Adaptimmune Therapeutics plc (NASDAQ: ADAP), a clinical-stage biopharmaceutical company, announced...